Freenome

Multiomics platform company developing blood-based tests for early cancer detection using machine learning to analyze cell-free DNA, methylation, proteins, and other biomarkers.

Location
South San Francisco, California, USA
Founded
2014
Investors
1
Categories
genomics, cancer-detection, liquid-biopsy, diagnostics, ai-ml

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33